Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Brainomix Limited
Brainomix is an AI-driven medical imaging company spun out from the University of Oxford, specializing in automated imaging biomarkers to improve diagnosis and treatment decisions in stroke, lung…
Brainomix Limited
Brainomix is an AI-driven medical imaging company spun out from the University of Oxford, specializing in automated imaging biomarkers to improve diagnosis and treatment decisions in stroke, lung…
TL;DR
Founded: 2010 (University of Oxford spin-out)
Flagship product: Brainomix 360 stroke platform (e-ASPECTS)
Recent financing: Series C announced/closed Mar 18, 2025 (~$18M / £14M)
Regulatory milestone: FDA clearance for e-ASPECTS (Mar 21, 2023)
Business model: SaaS AI medical-imaging software for hospitals and clinical trials
Company Overview
Problem Domain
Medical imaging for acute stroke assessment and other therapeutic areas with unmet diagnostic needs (lung fibrosis, cancer).
Founded
2010
Industry
Hospitals and Health Care
Tech Stack
Funding Track Record
18,000,000
Reported as £14M / $18M; new investor Hostplus via IP Group Hostplus Innovation Fund
16,000,000
Reported as £16M (participation from Tencent and Oxford University Innovation Fund)
7,000,000
Earlier round with participation from Boehringer Ingelheim Venture Fund, Chimera Partners and Oxford University Innovation
Investor Signal
“Backed by healthtech investors including Parkwalk Advisors, Boehringer Ingelheim Venture Fund, Hostplus (via IP Group), Tencent, Chimera Partners, Oxford University Innovation, and others”
